Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
Details for Australian Patent Application No. 2003245526 (hide)
International Classifications
Event Publications
25 September 2003 Complete Application Filed
Priority application(s): 10/177,566 20.06.02 US
4 March 2004 Application Open to Public Inspection
Published as AU-B-2003245526
5 April 2007 Application Accepted
Published as AU-B-2003245526
2 August 2007 Standard Patent Sealed
15 May 2008 Section 223 Application Received
Amgen Inc. An application to extend the time from 03 Sep 2006 to 03 Mar 2008 in which to file search results has been filed . Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2005
3 July 2008 Section 223 Application Allowed
Amgen Inc. The time in which to file search results has been extended to 03 Mar 2008. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 Extensions of Time, Section 223 2004
14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser